GOOD ASSETS
SAB 5134 Share Price
RM3.05
klse: Southern Acids (M) Berhad
Stock Information
Board : Main
Shariah : Shariah Compliant
Sector : Palm Oil Products CPO Crude Palm Oil Healthcare Products
Address: Level 29, Centro Tower, No 8, Jalan Batu Tiga Lama, 41300 Klang, Selangor
Contact: +603-32583333
Website: https://www.southernacids.com/
Stock Background
Southern Acids (M) Berhad is an investment holding company which markets oleochemical products for commercial use. Through its subsidiaries, the Company also provides administrative services, operates private hospitals, oil palm plantations, and warehouses. Southern Acids also develops property and has operation in bulk conveyor.
Profit Analysis: SAB 5134
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 22/05/26 | 201,821 | 34,563 | 23,562 |
| 23/02/26 | 235,946 | 14,606 | 4,850 |
| 19/11/25 | 255,056 | 18,008 | 9,287 |
| 29/08/25 | 226,050 | 8,343 | -321 |
| 29/05/25 | 248,273 | 8,526 | 4,907 |
| 19/02/25 | 303,149 | 41,328 | 24,959 |
| 26/11/24 | 298,072 | 12,421 | 5,160 |
| 23/08/24 | 241,036 | 9,989 | 1,677 |
| 30/05/24 | 227,604 | 10,341 | 5,608 |
| 29/02/24 | 232,576 | 11,901 | 4,565 |
| 28/11/23 | 232,458 | 2,295 | -5,378 |
| 29/08/23 | 215,325 | 19,051 | 9,129 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 919 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | 52,226 |
| Last 4 Quarter EPS (sen) | 27.3 |
| Last 4 Quarter PER | 7.94 |
| Last 4 Quarter Dividend (sen) | 500.00 |
| Last 4 Quarter Dividend Yield (%) | 1.65 |
| Net Tangible Assets (RM) | 5.71 |
| Goodwill (RM) | 0 |
| Cash (RM’000) | 401,500 |
| Debt (RM’000) | 17,710 |
| Total Debt (RM’000) | 123,710 |
| Net Assets (RM’000) | 765,350 |
| Current Ratio | 6.56 |
| Quick Ratio | 5.63 |
| Cash Ratio | 4.16 |
Technical
Technical Analysis
| MACD (26 vs 12) | -4.003 |
|---|---|
| Exponential Moving Average 5 | 3.082 |
| Exponential Moving Average 20 | 3.047 |
| Exponential Moving Average 90 | 3.154 |
| Relative Strength Index 14 | 0.50 |
| Stochastic %D 3 | 0.20 |
| Stochastic %K 14 | 0.10 |
10 reviews for SAB 5134
Show all Most Helpful Highest Rating Lowest Rating
Only logged in customers who have purchased this product may leave a review.
Stock Profit Analysis
-
BNASTRA 7195 ★★★★★RM2.14 - PETRONM 3042 ★★★★★RM3.44
- CMSB 2852 ★★★★★RM1.00
- SUNREIT 5176 ★★★★★RM2.23
Salary Proof
BURSA MALAYSIA –
Profit before tax decreased 50.0% to RM74.9 million from RM149.9 million achieved in the preceding financial year. Our revenue performance was largely impacted by lower contributions from both Oleochemical Manufacturing and Milling & Cultivation. Faced with such global headwinds, we remain cautious on the Group’s prospects. Near term, we will continue with our efforts to strengthen our operational platform and sustain a healthy balance sheet in navigating through these external challenges.
BURSA MALAYSIA –
Our Group revenue declined 5.7% to RM280.1 million from RM297.0 million. The decline was due to lower revenue contribution from Oleochemical Manufacturing as compared to the first quarter of FY2023. Group PBT rose 8.0% to RM26.6 million from RM24.7 million achieved in the immediate preceding quarter. Our Milling & Cultivation and Healthcare Services achieved higher PBT, whilst our Oleochemical Manufacturing incurred LBT in the second quarter of FY2023.
BURSA MALAYSIA –
The Group’s profit before tax decreased by RM2.266 million to RM2.694 million in the current quarter as compared to RM4.960 million in the immediate preceding quarter. The decrease in the profit generated in the current quarter was mainly due to the gain on disposal of freehold land, factory building and plant and machinery recorded in the immediate preceding quarter.
BURSA MALAYSIA –
Group PBT decreased 16.0% to RM29.7 million from RM35.4 million reported in the preceding quarter. This was mainly due to a lower contribution from our Oleochemical Segment, which fell 86.0% in the comparative period.
BURSA MALAYSIA –
The Group revenue increased 16.0% to RM258.0 million from RM222.4 million. The higher revenue was due to stronger revenue growth across all our three core business Segments. Group PBT was sharply higher at RM35.4 million from RM14.6 million achieve in the previous quarter. All our three core business Segments delivered improved profit performance in the quarter under review.
BURSA MALAYSIA –
Group PBT increased 35.5% to RM14.6 million from RM10.8 million reported in the previous quarter. This was mainly due to a stronger performance from the Oleochemical and Milling & Estate Segments as well as a gradual recovery in the Healthcare Segment.
REMUNERATION STUDY –
In Financial Year End 2020, the directors’ remuneration was 3.66 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 57.9 million and auditor’s remuneration of 285 thousands
BURSA MALAYSIA –
Group PBT increased 147.6% to RM21.2 million from RM8.5 million reported in the previous quarter. This was mainly due to a markedly improved performance in the Milling & Estate Segment, favorable foreign exchange movements and a low base effect in the immediate preceding quarter.
BURSA MALAYSIA –
Group PBT decreased 54.0% to RM8.5 million from RM18.6 million reported in the previous quarter. This was mainly due to a high base effect from the bumper performance in our Milling & Estate Segment in the immediate preceding quarter.
Investing Malaysia –
Average investing volume for Southern Acids (Malaysia) Bhd in the past three months in stock market was 2.3k lots
Investing Malaysia –
SAB gets a score of 25.07 in our equity and assets quality test based on current share price of RM3.74
Investing Malaysia –
Southern Acids (Malaysia) Bhd gets a score of 23.37 in our stability test after the balance sheet, money statement study
Investing Malaysia –
Stock code of 5134 in Bursa Malaysia declared adjusted 1.34% dividend yield in past few years
Investing Malaysia –
SAB is estimated to have a profit consensus of 26.81 millions, with an adjusted market capitalization of 538.63 millions
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 3.54 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 51.9 million and auditor’s remuneration of 256 thousands